GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 424 filers reported holding GLOBUS MED INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,893,303 | -0.1% | 38,133 | +19.8% | 0.08% | +7.0% |
Q2 2023 | $1,895,396 | +5.1% | 31,834 | 0.0% | 0.07% | 0.0% |
Q1 2023 | $1,803,078 | -34.2% | 31,834 | -13.6% | 0.07% | -35.5% |
Q4 2022 | $2,740,269 | +25.7% | 36,834 | +0.6% | 0.11% | +12.2% |
Q3 2022 | $2,180,000 | +9.0% | 36,612 | +2.7% | 0.10% | +14.0% |
Q2 2022 | $2,000,000 | -23.9% | 35,634 | 0.0% | 0.09% | -8.5% |
Q1 2022 | $2,628,000 | +2.2% | 35,634 | 0.0% | 0.09% | +8.0% |
Q4 2021 | $2,572,000 | -4.7% | 35,634 | +1.1% | 0.09% | -11.2% |
Q3 2021 | $2,699,000 | +5.3% | 35,242 | +6.6% | 0.10% | +6.5% |
Q2 2021 | $2,564,000 | +21.9% | 33,075 | -1.0% | 0.09% | +15.0% |
Q1 2021 | $2,104,000 | -3.5% | 33,425 | 0.0% | 0.08% | -20.0% |
Q4 2020 | $2,180,000 | +31.7% | 33,425 | 0.0% | 0.10% | +33.3% |
Q3 2020 | $1,655,000 | +2.7% | 33,425 | -1.0% | 0.08% | -2.6% |
Q2 2020 | $1,611,000 | -6.6% | 33,764 | -16.8% | 0.08% | -21.4% |
Q1 2020 | $1,724,000 | -27.5% | 40,560 | +0.4% | 0.10% | -6.7% |
Q4 2019 | $2,378,000 | +11.2% | 40,389 | -3.4% | 0.10% | +7.1% |
Q3 2019 | $2,138,000 | +18.9% | 41,830 | -1.6% | 0.10% | +19.5% |
Q2 2019 | $1,798,000 | -13.5% | 42,508 | +1.0% | 0.08% | -15.5% |
Q1 2019 | $2,079,000 | +14.2% | 42,093 | 0.0% | 0.10% | -2.0% |
Q4 2018 | $1,821,000 | -22.6% | 42,093 | +1.6% | 0.10% | -9.2% |
Q3 2018 | $2,352,000 | -17.4% | 41,450 | -26.6% | 0.11% | -20.4% |
Q2 2018 | $2,848,000 | -10.6% | 56,450 | -11.7% | 0.14% | -10.5% |
Q1 2018 | $3,186,000 | +6.0% | 63,950 | -12.6% | 0.15% | +11.7% |
Q4 2017 | $3,006,000 | +38.4% | 73,150 | +0.7% | 0.14% | +33.0% |
Q3 2017 | $2,172,000 | -9.8% | 72,654 | 0.0% | 0.10% | -12.0% |
Q2 2017 | $2,408,000 | +11.9% | 72,654 | 0.0% | 0.12% | +10.4% |
Q1 2017 | $2,151,000 | +13.6% | 72,654 | -4.8% | 0.11% | +11.6% |
Q4 2016 | $1,894,000 | +73.8% | 76,351 | +58.1% | 0.10% | +61.0% |
Q3 2016 | $1,090,000 | -5.2% | 48,300 | 0.0% | 0.06% | -21.3% |
Q2 2016 | $1,150,000 | +0.3% | 48,300 | 0.0% | 0.08% | -1.3% |
Q1 2016 | $1,147,000 | -14.6% | 48,300 | 0.0% | 0.08% | -16.5% |
Q4 2015 | $1,343,000 | +34.7% | 48,300 | 0.0% | 0.09% | +28.2% |
Q3 2015 | $997,000 | – | 48,300 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |